U.S. Life Sciences Stock News

Corcept Therapeutics FY 2025 earnings snapshot Corcept Therapeutics (CORT) has wrapped up FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.24, alongside net income of US$25.4 million. Over the past six quarters, the company has seen revenue move from US$181.9 million in Q4 2024 to a range between US$157.2 million and US$207.6 million per quarter, while basic EPS has ranged between US$0.19 and US$0.45. With a trailing 12 month net profit margin of 13.1% compared to 20.7% a...

Pebblebrook Hotel Trust (NYSE:PEB) recently completed a $450 million senior unsecured term loan. The company used part of the proceeds to repay certain mortgages and address near term debt maturities. Management also restored full capacity on its revolving credit facility, increasing available liquidity. Pebblebrook Hotel Trust, trading at $12.24, has had mixed share performance, with a 6.0% return year to date and a 4.6% return over the past year, but weaker 3 year and 5 year returns of...

If you are wondering whether Perfect's current share price reflects its true worth, this breakdown will help you connect the recent market action to what the numbers actually say about value. Perfect's share price closed at US$1.38, with returns of a 5.5% decline over 7 days, a 17.4% decline over 30 days, a 20.2% decline year to date, a 27.7% decline over 1 year and 81.9% and 86.1% declines over 3 and 5 years. This performance sits against a backdrop of ongoing market attention on software...

ONEOK (NYSE:OKE) reported double digit net income and adjusted EBITDA growth for 2025. The company exceeded synergy targets from recent acquisitions, including Magellan, and retired a significant amount of long term debt. ONEOK raised its quarterly dividend by 4% and continued integrating acquired assets through 2025. Management outlined plans for 2026 that include expansion into fee based earnings and energy solutions for data centers. ONEOK is a large midstream operator focused on natural...

Hovnanian Enterprises (HOV) opened its 2026 financial year with Q1 revenue of US$632 million and basic EPS of US$2.80, setting a measured tone after a volatile run of quarterly results. The company has seen quarterly revenue move from US$674 million and EPS of US$3.88 in Q1 2025 through periods of both profit and loss, including revenue of US$818 million with a loss per share of US$0.60 in Q4 2025. This puts today’s figures in the middle of a choppy trend that keeps the spotlight firmly on...

Kiniksa Pharmaceuticals International (KNSA) closed FY 2025 with Q4 revenue of US$202.1 million and basic EPS of US$0.19, alongside net income of US$14.2 million. On a trailing twelve month basis, revenue was US$677.6 million with basic EPS of US$0.80 and net income of US$59.0 million. The company’s quarterly revenue moved from US$122.5 million and a basic EPS loss of US$0.12 in Q4 2024 to US$202.1 million and basic EPS of US$0.19 in Q4 2025. Over the same period, trailing twelve month net...

What Avidity Biosciences’ Recent Returns Signal for Investors Avidity Biosciences (RNA) has drawn attention after a 1 day return close to flat, modest moves over the past week and month, and a very large total return over the past year. For investors, those figures sit alongside a revenue base of US$18.755 million and a reported net loss of US$684.631 million. This highlights that the company remains firmly in a development focused phase. See our latest analysis for Avidity Biosciences. With...

Day One Biopharmaceuticals (DAWN) just reported its FY 2025 numbers, with Q4 total revenue of US$53.7 million and a net loss of US$21.3 million, setting the tone for how investors will read the year as a whole. The company has seen quarterly revenue move from US$29.2 million in Q4 2024 to US$53.7 million in Q4 2025, while Basic EPS shifted from a loss of US$0.64 per share in Q4 2024 to a loss of US$0.19 per share in Q3 2025, giving investors a clear view of how top line scale and loss levels...

Universal Insurance Holdings FY 2025 Earnings Snapshot Universal Insurance Holdings (UVE) has wrapped up FY 2025 with fourth quarter total revenue of US$407.9 million and basic EPS of US$2.40, alongside net income of US$66.6 million as investors weigh these results against a year where net profit margin moved from 3.9% to 11.4% and earnings growth was very large at about 210.5% year over year. Over recent periods the company has seen total revenue shift from US$384.8 million and basic EPS of...

Euroseas (NasdaqCM:ESEA) has wrapped up FY 2025 with fourth quarter revenue of US$57.4 million and basic EPS of US$5.82, setting the tone for a year where trailing 12 month revenue reached US$227.9 million and EPS came in at US$19.73. Over recent periods, the company has seen quarterly revenue move from US$53.3 million in Q4 2024 to around US$56.3 million to US$57.4 million across 2025. Quarterly EPS shifted from US$3.51 in Q4 2024 to a range of US$4.27 to US$5.82 in 2025, with these earnings...

Q2 2026 earnings snapshot Manchester United (MANU) has just posted Q2 2026 results with revenue of £190.3 million and basic EPS of £0.024, alongside net income of £4.2 million, putting a profit quarter next to a still loss-making trailing twelve month profile. The club has seen quarterly revenue move between £143.1 million and £198.7 million over the past six reported periods, while basic EPS has ranged from a loss of £0.163 to a profit of £0.024, giving investors a mixed read on headline...

If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value. Chemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for...

First Citizens BancShares (FCNCA) has wrapped up FY 2025 with Q4 total revenue of US$2.4b and basic EPS of US$45.78, alongside net income of US$566m that feeds into a trailing 12 month net profit margin of 23.8%, compared with 29.1% a year earlier. Over recent periods, the bank has seen total revenue move between US$2.1b and US$2.4b per quarter and quarterly EPS range from US$34.47 to US$49.18. This gives investors a clear set of numbers to weigh against a five year earnings growth rate of...

Innoviz Technologies (INVZ) just posted its FY 2025 numbers, with Q4 revenue at US$12.7 million and a basic EPS loss of US$0.10, alongside a trailing twelve month revenue base of US$55.1 million and a full year EPS loss of US$0.34. Over the past two reported years, the company has seen quarterly revenue range from US$4.5 million to US$17.4 million and basic EPS losses between US$0.07 and US$0.15. This gives investors a clearer view of how the top line and per share results have been tracking...

Capri Holdings (NYSE:CPRI) has appointed Tyler Reddien as its new Chief Financial Officer and Chief Operating Officer. Reddien steps into the dual role as the company pursues its plans in the global luxury fashion market. Capri Holdings, the owner of luxury brands in the global fashion and accessories space, now has a single executive overseeing both its finance and operations functions. For investors, a combined CFO and COO role can concentrate responsibility for capital allocation, cost...

SPX Technologies (SPXC) has wrapped up FY 2025 with fourth quarter revenue of US$637.3 million and basic EPS of US$1.57, while trailing twelve month revenue came in at about US$2.3 billion alongside EPS of US$5.13. Over the past few quarters the company has seen revenue move from US$533.7 million in Q4 2024 to US$637.3 million in Q4 2025, with basic EPS stepping from US$1.22 to US$1.57 over the same period. Those results sit on top of trailing earnings growth of 21.7% and a net margin of...

Cytokinetics (CYTK) has capped FY 2025 with Q4 revenue of US$17.8 million and a basic EPS loss of US$1.52, anchored by a net loss of US$183.0 million. This sets the tone for how investors are reading the latest update against a year of heavy spending. Over recent periods, the company has seen quarterly revenue range from US$1.6 million to US$66.8 million in FY 2025, while basic EPS losses have moved between US$1.12 and US$2.55. This gives a clear picture of a business that is still investing...

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...

AbCellera Biologics (ABCL) closed out FY 2025 with Q4 revenue of US$44.9 million and a basic EPS loss of US$0.03, alongside trailing 12 month revenue of US$75.1 million and a full year basic EPS loss of US$0.49, providing a snapshot of a business still investing heavily ahead of profitability. Over the past few quarters, the company reported revenue of US$4.2 million in Q1 2025, US$17.1 million in Q2, US$9.0 million in Q3 and US$44.9 million in Q4, while quarterly EPS losses moved from...

If you are wondering whether Air Lease is still offering value at its current share price, this article will walk through what the numbers actually say about the stock. With the share price at US$64.85 and returns of 0.1% over 7 days, 0.7% over 30 days, 1.1% year to date, 36.8% over 1 year, 57.7% over 3 years and 50.1% over 5 years, many investors are asking whether expectations and valuation are now in sync. Recent news on Air Lease has focused on its role in supplying aircraft to airlines...

American Integrity Insurance Group closed FY 2025 with fourth quarter revenue of US$68.1 million and basic EPS of US$1.07, rounding out a twelve month stretch that produced total revenue of US$276.5 million and basic EPS of US$5.65. Over the past year, the company has seen revenue move from US$204.4 million to US$276.5 million and basic EPS adjust from US$309.45 to US$5.65 on a trailing twelve month basis, giving investors a detailed view of how the top and bottom lines have evolved. With net...

Golar LNG (NasdaqGS:GLNG) has wrapped up FY 2025 with Q4 revenue of US$132.8 million and basic EPS of US$0.10, rounding out a year in which trailing twelve month revenue sat at US$393.5 million and EPS reached US$0.64. Over the past few quarters, the company has seen revenue range from US$62.5 million in Q1 2025 to US$132.8 million in Q4 2025, with quarterly EPS moving between US$0.08 and US$0.31 across the year. This has set the backdrop for a trailing net profit margin of 18.3% compared...

Allot (NasdaqGS:ALLT) has wrapped up FY 2025 with Q4 revenue of US$28.4 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$102.0 million and EPS of US$0.08. Over the past few quarters, the company has reported revenue of US$24.9 million in Q4 2024, followed by US$23.2 million in Q3 2024, and then US$23.2 million, US$23.2 million, US$24.1 million, US$26.4 million and US$28.4 million across FY 2025. Over the same period, quarterly EPS moved from US$0.01 in Q4 2024...